Portolan Capital Management, LLC Maxcyte, Inc. Transaction History
Portolan Capital Management, LLC
- $1.32 Billion
- Q4 2024
A detailed history of Portolan Capital Management, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Portolan Capital Management, LLC holds 1,135,613 shares of MXCT stock, worth $3.51 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
1,135,613
Previous 1,303,438
12.88%
Holding current value
$3.51 Million
Previous $5.07 Million
6.82%
% of portfolio
0.36%
Previous 0.4%
Shares
8 transactions
Others Institutions Holding MXCT
# of Institutions
123Shares Held
69.8MCall Options Held
8.7KPut Options Held
6K-
Cadian Capital Management, LP New York, NY9.34MShares$28.9 Million2.26% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$25.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$16.8 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$15.6 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.41MShares$13.6 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $314M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...